Trial Profile
Patient Reported Outcomes with Fingolimod in Local Experience (PROFILE)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Jun 2016
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms PROFILE
- Sponsors Novartis
- 17 May 2016 Status changed from recruiting to completed.
- 13 Nov 2014 New trial record